Format

Send to

Choose Destination
See comment in PubMed Commons below
Neuropharmacology. 2010 Jun;58(7):972-80. doi: 10.1016/j.neuropharm.2009.12.017. Epub 2010 Jan 6.

Blood-brain barrier permeability and tPA-mediated neurotoxicity.

Author information

1
Department of Clinical Biochemistry, Hebrew University - Hadassah Medical Center, Jerusalem, Israel.

Abstract

Tissue type plasminogen activator (tPA) can induce neuronal apoptosis, disrupt the blood-brain barrier (BBB), and promote dilation of the cerebral vasculature. The timing, sequence and contributions of these and other deleterious effects of tPA and their contribution to post-ischemic brain damage after stroke, have not been fully elucidated. To dissociate the effects of tPA on BBB permeability, cerebral vasodilation and protease-dependent pathways, we developed several tPA mutants and PAI-1 derived peptides constructed by computerized homology modeling of tPA. Our data show that intravenous administration of human tPA to rats increases BBB permeability through a non-catalytic process that is associated with reversible neurotoxicity, brain damage, mortality and contributes significantly to its brief therapeutic window. Furthermore, our data show that inhibiting the effect of tPA on BBB function without affecting its catalytic activity, improves outcome and significantly extends its therapeutic window in mechanical as well as in thromboembolic models of stroke.

PMID:
20060006
PMCID:
PMC4423729
DOI:
10.1016/j.neuropharm.2009.12.017
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center